Skip to main content

Renton Hollings's Form 4 filing

Anaptysbio, Inc (ANAB) · filed Jul 17, 2024

Accession no.
0001415889-24-019676
Filed
Jul 17, 2024
Trade date
Jul 15, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $306.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Renton HollingsCIK 0001187333Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 15, 2024Common StockMOption exerciseAcquired+10,000$6.93+$69,30011,950Direct
Jul 15, 2024Common StockSSaleDisposed−7,103$30.50−$216,641.54,847Direct
Jul 15, 2024Common StockSSaleDisposed−2,897$30.98−$89,749.061,950Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 15, 2024Common StockMOption exerciseDisposed−10,000$0.00$030,925Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)